Lineage Cell Therapeutics, Inc. · Brief

Next report

5 days

Nov 5 · after closeest.Q3 FY26

Expected move

No implied move.

—≥ implied

Q2 FY26—▼−2.65%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−2.65%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · est.

Bull2

129managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+14.05%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

7managers holding four fifths of reported value13F · Jun 30 '26

8 of 22of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Oct 26 '26once per report · top 2 per case

LCTX report session

No linked exposure.

Oct 22impliedImplied move: ±14.5% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.